Researchers have developed a new technology that can be used to deliver the gene-editing tool CRISPR/Cas9 into prostate cancer cells without the need for viral vectors, a proof-of-concept study demonstrates. The study, “ZIF-C for targeted RNA interference and CRISPR/Cas9 based gene editing in prostate cancer,” was published in Chemical Communications. Cancer cells harbor genetic changes that enable them to grow and survive unchecked. In the broadest sense, gene therapy for cancer aims to reverse or deter these…
You must be logged in to read/download the full post.
The post Study Describes New Way to Place CRISPR/Cas9 Into Cancer Cells appeared first on BioNewsFeeds.